Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (6)

2024

  1. Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

    Behavioral and Brain Functions , Vol. 20, Núm. 1

  3. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2021

  1. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

2018

  1. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

    GLIA, Vol. 66, Núm. 8, pp. 1752-1762

1999

  1. Thalamic interaction between the input and the output systems of the basal ganglia

    Journal of Chemical Neuroanatomy, Vol. 16, Núm. 3, pp. 187-200